On March 18th 2019, MGI was invited to present at the 3rd Annual Nordic Precision Medicine Forum’s breakout session: "A New Era of ‘Broadband’ Sequencing to Realise the Full Benefits of Genomic Information. In the breakout session, speakers shared the outstanding performance of the MGI sequencing platform. At the same time, MGI officially launched the “Global Sequencer User Program” in Europe. MGI made a breakthrough from 0 to 1 within five years, and independently developed a varie...

MGI showcased its packages for microbial detection in a series of activities and presentations March 16-20 in Southeast Asia, receiving an enthusiastic response. high-throughput sequencing platform integrated with a pathogen detection system, called Microbial Detection Total Solution. The package can perform fast, accurate and comprehensive pathogen screening. She presented several cases where MGI's microbial packages based on high-throughput sequencing played a crucial role in detecting p...

The 3rd Annual Nordic Precision Medicine Forum will be held at the Hotel Birger Jarl in Stockholm, Sweden from March 18 to 19. MGI is invited to present at the breakout session: "A New Era of 'Broadband' Sequencing to Realise the Full Benefits of Genomic Information. MGI will introduce the ultra-high-throughput genetic sequencer MGISEQ-T7 and its disruptive single tube long fragment read (stLFR) technology, enabling participants to gain a better understanding of this new era of "broadband"...

MGI's "Broadband" Sequencing Delivers Bandwidth to Achieve Genome for All Vision SAN JOSE, CA, March 4, 2019 – MGI, a subsidiary of BGI Group, unveiled its novel CoolNGS chemistry, a disruptive new sequencing approach for its DNBseqTM sequencing technology that enhances the throughput, accuracy, read length and cost effectiveness of DNA sequencing. As a global leader in innovative sequencing platforms, MGI is committed to developing and producing advanced genetic sequencing instruments,...

MGI, a subsidiary of BGI Group, exhibited its genetic sequencer MGISEQ-2000 in conjunction with the local distributor BMS at the 15th KOGO Winter Symposium organized by Korea Genome Organization February 11-13, drawing extensive attention in the Korean NGS market. Dr. Chen Fang introduced the ultra-high-throughput genetic sequencer MGISEQ-T7 in her presentation to the Korean audience. She also introduced the history of sequencing technology and how MGI is dedicated to improving the availability...

MGI, a subsidiary of BGI Group, announced it is expanding in the Middle East with a new office in Dubai to better serve partners and clients in the region. MGI's expansion in the region will include UAE, Qatar and Saudi Arabia, serving universities, hospitals, healthcare institutions and other customers and partners throughout the Middle East. MGI produces genetic sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare. Its proprietary t...